Atorvastatin Inhibits gp91 phox Circulating Levels in Patients With Hypercholesterolemia
- 1 February 2010
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 30 (2), 360-367
- https://doi.org/10.1161/atvbaha.109.198622
Abstract
Objective— The inhibition of oxidative stress is among the most relevant pleiotropic effects of statins. The mechanism by which statins exert their antioxidant effect in vivo is still undefined. NADPH oxidase is among the most important sources of reactive oxygen species involved in atherosclerotic disease. Methods/Results— We developed an ELISA to evaluate serum levels of soluble-gp91 phox , the catalytic core of phagocyte NADPH oxidase. In a cross-sectional study performed in 30 hypercholesterolemic patients and in 20 controls, serum soluble-gp91 phox and urinary isoprostane, a marker of oxidative stress, were measured. The 2 variables were also measured in hypercholesterolemic patients, randomized to diet (n=15), or diet plus atorvastatin (10 mg daily, n=15) and followed for 30 days. Compared to controls, hypercholesterolemic patients had higher and significantly correlated ( R =0.71; P phox ( P P phox (−33%, P P P Conclusion— Our study demonstrates that statins exert an antioxidant effect via inhibition of soluble gp91 phox expression.Keywords
This publication has 29 references indexed in Scilit:
- Primary Prevention of Cardiovascular Mortality and Events With Statin TreatmentsJournal of the American College of Cardiology, 2008
- Free radicals and antioxidants in normal physiological functions and human diseaseThe International Journal of Biochemistry & Cell Biology, 2007
- Early decrease of oxidative stress by atorvastatin in hypercholesterolaemic patients: effect on circulating vitamin EEuropean Heart Journal, 2007
- Fluvastatin Alters Platelet Aggregability in Patients With HypercholesterolemiaArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Early Increase of Oxidative Stress and Soluble CD40L in Children With HypercholesterolemiaJournal of the American College of Cardiology, 2007
- Nox2 Is Determinant for Ischemia-Induced Oxidative Stress and Arterial Vasodilatation: A Pilot Study in Patients With Hereditary Nox2 DeficiencyArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- The pleiotropic effects of statinsCurrent Opinion in Cardiology, 2005
- Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statinsThe Lancet, 2005
- Antioxidant effect of simvastatin is not enhanced by its association with α-tocopherol in hypercholesterolemic patientsFree Radical Biology & Medicine, 2004
- Statins Promote Potent Systemic Antioxidant Effects Through Specific Inflammatory PathwaysCirculation, 2003